CANY
LLY icon

Caxton Associates (New York)’s Eli Lilly LLY Stock Holding History

Caxton Associates (New York)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,670
Closed -$3.25M – 590
2024
Q3 		$3.25M Sell
3,670
-1,461
-28% -$1.31M 0.12% 60
2024
Q2 		$4.65M Buy
5,131
+428
+9% +$342K 0.16% 72
2024
Q1 		$3.66M Buy
+4,703
New +$3.35M 0.21% 58
2023
Q1 		– Sell
-211,000
Closed -$77.2M – 572
2022
Q4 		$77.2M Buy
+211,000
New +$74.8M 5.15% 4
2022
Q1 		– Sell
-3,143
Closed -$868K – 621
2021
Q4 		$868K Sell
3,143
-1,810
-37% -$459K 0.09% 140
2021
Q3 		$1.14M Buy
+4,953
New +$1.22M 0.13% 86
2020
Q4 		– Sell
-3,856
Closed -$571K – 242
2020
Q3 		$571K Buy
3,856
+1,556
+68% +$241K 0.06% 104
2020
Q2 		$378K Sell
2,300
-100
-4% -$15.3K 0.03% 192
2020
Q1 		$333K Buy
+2,400
New +$330K 0.06% 239
2019
Q4 		– Sell
-5,786
Closed -$647K – 483
2019
Q3 		$647K Buy
5,786
+2,096
+57% +$233K 0.13% 93
2019
Q2 		$409K Buy
+3,690
New +$435K 0.05% 223
2018
Q4 		– Sell
-2,333
Closed -$250K – 391
2018
Q3 		$250K Buy
+2,333
New +$233K 0.02% 349
2018
Q1 		– Sell
-16,228
Closed -$1.37M – 385
2017
Q4 		$1.37M Buy
+16,228
New +$1.38M 0.07% 166
2016
Q3 		– Sell
-8,890
Closed -$700K – 219
2016
Q2 		$700K Sell
8,890
-3,581
-29% -$270K 0.02% 172
2016
Q1 		$898K Sell
12,471
-11,182
-47% -$846K 0.06% 106
2015
Q4 		$1.99M Buy
23,653
+2,337
+11% +$194K 0.32% 51
2015
Q3 		$1.78M Buy
+21,316
New +$1.8M 0.11% 66

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Caxton Associates (New York)'s LLY Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 3,670 shares — an estimated $3.25M sold.

Caxton Associates (New York) first reported a position in LLY in Q3 2015 and held it in 17 quarters. The position peaked at $77.2M in Q4 2022. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,670 Eli Lilly shares in Q4 2024, an estimated $3.25M.
  • Caxton Associates (New York) first reported a position in Eli Lilly in Q3 2015 and held it in 17 quarters.
  • Caxton Associates (New York)'s Eli Lilly position peaked at $77.2M in Q4 2022.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.